Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126883782 | 12688378 | 2 | F | 20160825 | 20160826 | 20160828 | EXP | CN-ROCHE-1818345 | ROCHE | LIANG Y, WAKELEE H AND NEAL J RELATIONSHIP OF DRIVER ONCOGENES TO LONG-TERM PEMETREXED RESPONSE IN NON-SMALL-CELL LUNG CANCER. CLINICAL LUNG CANCER 2015;16 (5):366-373. | 0.00 | Y | 0.00000 | 20160829 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126883782 | 12688378 | 1 | PS | Erlotinib | ERLOTINIB | 1 | Unknown | U | 53728 | ||||||||||
| 126883782 | 12688378 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | ||||||||||
| 126883782 | 12688378 | 3 | SS | PEMETREXED | PEMETREXED | 1 | Unknown | U | 0 | ||||||||||
| 126883782 | 12688378 | 4 | SS | PLATINUM | PLATINUM | 1 | Unknown | U | 0 | ||||||||||
| 126883782 | 12688378 | 5 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | U | 0 | ||||||||||
| 126883782 | 12688378 | 6 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 126883782 | 12688378 | 7 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | U | 0 | ||||||||||
| 126883782 | 12688378 | 8 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126883782 | 12688378 | 9 | SS | CRIZOTINIB | CRIZOTINIB | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126883782 | 12688378 | 1 | Non-small cell lung cancer |
| 126883782 | 12688378 | 2 | Non-small cell lung cancer |
| 126883782 | 12688378 | 3 | Non-small cell lung cancer |
| 126883782 | 12688378 | 4 | Non-small cell lung cancer |
| 126883782 | 12688378 | 5 | Non-small cell lung cancer |
| 126883782 | 12688378 | 6 | Non-small cell lung cancer |
| 126883782 | 12688378 | 7 | Non-small cell lung cancer |
| 126883782 | 12688378 | 8 | Non-small cell lung cancer |
| 126883782 | 12688378 | 9 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126883782 | 12688378 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126883782 | 12688378 | Alanine aminotransferase abnormal | |
| 126883782 | 12688378 | Anaemia | |
| 126883782 | 12688378 | Blood creatinine abnormal | |
| 126883782 | 12688378 | Constipation | |
| 126883782 | 12688378 | Decreased appetite | |
| 126883782 | 12688378 | Diarrhoea | |
| 126883782 | 12688378 | Epistaxis | |
| 126883782 | 12688378 | Fatigue | |
| 126883782 | 12688378 | Hypertension | |
| 126883782 | 12688378 | Hypokalaemia | |
| 126883782 | 12688378 | Hyponatraemia | |
| 126883782 | 12688378 | Left ventricular dysfunction | |
| 126883782 | 12688378 | Leukopenia | |
| 126883782 | 12688378 | Nausea | |
| 126883782 | 12688378 | Nephrotic syndrome | |
| 126883782 | 12688378 | Neuropathy peripheral | |
| 126883782 | 12688378 | Neutropenia | |
| 126883782 | 12688378 | Oedema | |
| 126883782 | 12688378 | Proteinuria | |
| 126883782 | 12688378 | Pulmonary embolism | |
| 126883782 | 12688378 | Rash | |
| 126883782 | 12688378 | Rhinitis | |
| 126883782 | 12688378 | Thrombocytopenia | |
| 126883782 | 12688378 | Thrombosis | |
| 126883782 | 12688378 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |